Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Eris Lifesciences Limited Call Transcript 2023

Jan 23, 2023

61253_rns_2023-01-23_f9b15b5e-8c75-42a5-af42-df02f18ac4d4.pdf

Call Transcript

Open in viewer

Opens in your device viewer

==> picture [594 x 125] intentionally omitted <==

Date: 23[rd ] January, 2023

Date: 23rdJanuary, 2023
To To
BSE Limited National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers Exchange Plaza
Dalal Street Bandra Kurla Complex
Mumbai- 400001 Bandra (E)
Mumbai-400051
Security Code: 540596 Symbol: ERIS

SUBJECT: TRANSCRIPT OF ANALYST AND INVESTOR CALL

Dear Sir/Madam,

This is to inform that the transcript of the Analyst and Investor call which was held after the announcement of financial results for the quarter ended, 31[st ] December 2022 is available on our website URL https://eris.co.in/financials/

(File name: Transcript of the Analyst and Investor Conference Call Q3FY23).

Thanking You,

For Eris Lifesciences Limited

MILIND Digitally signed by MILIND TALEGAONK TALEGAONKAR Date: 2023.01.23 AR 19:05:55 +05'30'

Milind Talegaonkar Company Secretary and Compliance Officer Mem. No. A26493

==> picture [595 x 68] intentionally omitted <==